European Medicines Agency organises public meeting on COVID-19 vaccines

The meeting, to be broadcast live on 11 December 2020, will inform EU citizens about the regulatory processes for the approval of COVID-19 vaccines and the Agency’s role in their development, evaluation, approval and safety monitoring.

SPS commentary:

Those interested in making an intervention during the public meeting can fill out a form for consideration by the EMA, who will select a group of people to speak at the meeting. There will also be a mailbox open during the meeting via EMA’s website for the public to make comments.

European Medicines Agency